Valuation : Progyny, Inc.

Market Cap 1.99B 1.72B 1.61B 1.47B 2.77B 190B 2.79B 19.11B 7.44B 96.25B 7.49B 7.33B 319B P/E 2026 *
20.2x
P/E 2027 * 17.1x
Enterprise Value 1.83B 1.57B 1.48B 1.35B 2.53B 174B 2.55B 17.5B 6.81B 88.16B 6.86B 6.71B 292B EV / Sales 2026 *
1.33x
EV / Sales 2027 * 1.08x
Free-Float
75.4%
Yield 2026 *
-
Yield 2027 * -
1 day-1.90%
1 week+0.39%
Current month-17.92%
1 month-17.92%
3 months-2.48%
6 months+45.83%
Current year-0.51%
1 week 25.37
Extreme 25.368
26.49
1 month 25.1
Extreme 25.095
31.82
Current year 16.1
Extreme 16.1
33.06
1 year 16.1
Extreme 16.1
33.06
3 years 13.39
Extreme 13.39
42.08
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
Director of Finance/CFO 60 15/09/2020
Chief Operating Officer 56 17/04/2025
Director TitleAgeSince
Chairman 66 01/01/2022
Director/Board Member 77 16/12/2016
Director/Board Member 58 01/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
7/14/26 A Tax

Chief Operating Officer

-3,437 0.0044%
6/3/26 A Tax

Chief Executive Officer

-5,361 0.0068%
6/2/26 A Tax

Chief Financial Officer

-437 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-1.90%+0.39%+9.14%-31.57% 1.99B
-0.69%-1.95%+26.62%-17.96% 353B
-0.31%-2.15%+22.23%-10.87% 85.54B
-0.76%-1.27%-7.92%+0.23% 73.69B
-0.71%-0.45%+24.13%-16.63% 46.3B
-0.64%-1.78%+117.69%+4.59% 31.99B
-0.73%+0.13%+8.46%-35.91% 10.42B
-1.87%-0.48%-19.68%+128.85% 2.83B
-1.77%+1.09%+54.46%+217.18% 2.25B
Average -1.04%+0.85%+26.12%+26.43% 67.52B
Weighted average by Cap. -0.65%+0.41%+25.94%-12.27%

Financials

2026 *2027 *
Net sales 1.37B 1.18B 1.11B 1.01B 1.91B 131B 1.92B 13.17B 5.12B 66.32B 5.16B 5.05B 220B 1.51B 1.3B 1.22B 1.12B 2.1B 144B 2.11B 14.49B 5.64B 72.96B 5.68B 5.55B 242B
Net income 106M 91.5M 85.92M 78.43M 147M 10.11B 148M 1.02B 396M 5.13B 399M 390M 16.98B 125M 108M 101M 92.53M 174M 11.93B 175M 1.2B 467M 6.05B 471M 461M 20.03B
Net Debt -168M -144M -136M -124M -232M -15.95B -234M -1.61B -625M -8.09B -629M -616M -26.78B -358M -308M -289M -264M -496M -34.06B -500M -3.43B -1.33B -17.27B -1.34B -1.31B -57.18B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
31/08/26 $25.55 -1.73% 397,748
28/08/26 $26.00 +0.54% 832,665
27/08/26 $25.86 -1.93% 1,162,376
26/08/26 $26.37 +2.13% 1,117,318
25/08/26 $25.82 +1.45% 1,405,947
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
26.00USD
Average target price
34.25USD
Spread / Average Target
+31.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGNY Stock